# TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

> **NCT06829784** · PHASE3 · RECRUITING · sponsor: **Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.** · enrollment: 660 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TQC2731 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06829784
- **Lead sponsor:** Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-21
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 660 (ESTIMATED)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06829784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06829784, "TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06829784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*